1) repaglinide
瑞格列奈
1.
Efficacy and safety of repaglinide tablet in type 2 diabetic patients;
瑞格列奈治疗2型糖尿病的有效性及安全性的评价
2.
Study of the function of Repaglinide on insulin secretion and oxidative stress in type 2 diabetes mellitus;
瑞格列奈对2型糖尿病胰岛素分泌和氧化应激作用的研究
3.
Effect of a combination of glargine plus repaglinide in 30 patients with type 2 diabetes mellitus;
甘精胰岛素联合瑞格列奈治疗2型糖尿病30例疗效观察
2) Repaglinide Tablets
瑞格列奈片
3) nateglinide
那格列奈
1.
Study on Stability of Nateglinide Polymorphism;
不同晶型那格列奈的稳定性研究
2.
Determination of Degree of Stripping of Nateglinide by Reversed Phase High Performance Liquid Chromatography;
反相高效液相色谱法测定那格列奈片剂的溶出度
4) mitiglinide
米格列奈
1.
Study of the synthesis of mitiglinide;
米格列奈的合成方法研究
2.
An Improved Synthesis Method of Cis-hexahydroisoindoline,the Intermediate of Mitiglinide;
米格列奈中间体顺式全氢异吲哚的合成工艺改进
3.
Determination of the enantiomers of mitiglinide by HPLC;
HPLC法检查米格列奈对映异构体限量
5) repaglinide
瑞格列耐
1.
Randomized controlled multicenter clinical trial of domestic nateglinide and imported repaglinide in the treatment of types 2 diabetes;
国产那格列奈和进口瑞格列耐治疗2型糖尿病随机双盲平行对照多中心临床试验
6) Repaglinide
瑞格列萘
1.
Study on Once Daily Insulin Glargine Combined with Repaglinide after Switching from Unsatisfied Therapeutic Effect Patients of Premixed Insulin Humulin 70/30 Injection Combined with Oral Drugs;
甘精胰岛素+瑞格列萘治疗预混胰岛素疗效不佳2型糖尿病患者的临床研究
补充资料：瑞格列奈
分子式：暂无
分子量：暂无
CAS号：135062-02-1
性质：暂无
制备方法：暂无
用途：降血糖药。
分子量：暂无
CAS号：135062-02-1
性质：暂无
制备方法：暂无
用途：降血糖药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条